WHO ICTRP trial
Investigating the effect of omega-3 supplementation on inflammatory indices of…
IRCT20151226025699N6 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20151226025699N6 |
|---|---|
| Public title | Investigating the effect of omega-3 supplementation on inflammatory indices of dialysis patients |
| Scientific title | The Effect of Omega-3 Supplementation on Inflammatory Clinical Markers and Body Composition in Hemodialysis Patients A randomized, triple-blind, placebo- controlled trial |
| Primary sponsor | Rasht University of Medical Sciences |
| Secondary sponsors | Zahrawi Pharmaceutical Company |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Patients with chronic kidney failure undergoing hemodialysis. Chronic kidney disease (CKD) |
| Interventions | Intervention 1: Intervention group: Omega-3 capsule contains 1000 mg of fish oil, 180 mg of EPA and 120 mg of DHA and auxiliary components of gelatin, glycerin, sodium methylparaben, sodium propylparaben. Three capsules of omega-3 fatty… |
| Registration date | Dec 24, 2022 |
| Target size | 120 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: